Hong Kong stocks surge | Jiahe Bio-B (06998.HK) rises over 17% in the afternoon, injection GB268 approved for clinical use, plans to develop treatment for late-stage solid tumors.

According to the WiseNews financial APP, Jiahe Biology-B (06998.HK) surged over 17% in the afternoon, rising by 14.98% to 3.76 Hong Kong dollars as of press time, with a turnover of 22.331 million Hong Kong dollars.